top of page

AGB: Not until a made-in-China mRNA vaccine

Not until a made-in-China mRNA vaccine: Alidad Tash By AGBrief

21 October 2022

Alidad Tash estimates Macau’s 2023 GGR to reach about 40 percent of 2019 levels and that we won’t be getting out of Covid Zero policy well into the second quarter of next year – once a Made-in-China mRNA has been approved, and administered to the vast majority of the Mainland’s population.

In a special edition of AGB’s Face-to-Face sessions the managing director of 2NT8 goes over some of the questions on the industry’s minds: Genting, Covid-zero, digital currency, next year’s GGR outlook.


Anchor 1 Fiction
bottom of page